| Stage | DUK | % of rev | AEP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.6B | 100.00% | $5.4B | 100.00% | DUK ×1.39 |
| Gross profit | $4.2B | 54.82% | $3.8B | 70.56% | AEP +15.7pp |
| Operating income | $2.0B | 26.99% | $1.2B | 22.90% | DUK +4.1pp |
| Pre-tax income | $1.3B | 17.19% | $770M | 14.14% | DUK +3.0pp |
| Net income | $1.1B | 15.08% | $747M | 13.72% | DUK +1.4pp |
| Stage | DUK | AEP | Gap · A − B |
|---|---|---|---|
| Revenue | $7.6B100.00% | $5.4B100.00% | DUK ×1.39 |
| Gross profit | 54.82%$4.2B | 70.56%$3.8B | AEP +15.7pp |
| Operating income | 26.99%$2.0B | 22.90%$1.2B | DUK +4.1pp |
| Pre-tax income | 17.19%$1.3B | 14.14%$770M | DUK +3.0pp |
| Net income | 15.08%$1.1B | 13.72%$747M | DUK +1.4pp |
No shared counterparties.